Carregant...
Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti‐cancer therapy?
DNA‐damaging strategies, such as radiotherapy and the majority of chemotherapeutic therapies, are the most frequently used non‐surgical anti‐cancer therapies for human cancers. These therapies activate DNA damage/replication checkpoints, which induce cell‐cycle arrest to provide the time needed to r...
Guardat en:
| Publicat a: | Cancer Sci |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659239/ https://ncbi.nlm.nih.gov/pubmed/22435685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02280.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|